Firm Secures Federal Circuit Affirmance for Medical Device Manufacturer in Glucose Test Strip Patent Litigation

November 25, 2019

On November 22, 2019, the Firm scored a major victory for two medical device manufacturers when the U.S. Court of Appeals for the Federal Circuit affirmed a district court decision granting summary judgment of noninfringement in a patent case involving blood-glucose test strips. The Federal Circuit applied the doctrine of prosecution history estoppel in affirming the district court’s ruling that our clients did not infringe the patents asserted against them.

To read press on the win, click here.